Literature DB >> 29433374

Objective evaluation of binaural summation through acoustic reflex measures.

Vishakha W Rawool1, Madaline Parrill1.   

Abstract

OBJECTIVE: A previous study [Rawool, V. W. (2016). Auditory processing deficits: Assessment and intervention. New York, NY: Thieme Medical Publishers, Inc., pp. 186-187] demonstrated objective assessment of binaural summation through right contralateral acoustic reflex thresholds (ARTs) in women. The current project examined if previous findings could be generalised to men and to the left ear.
DESIGN: Cross-sectional. STUDY SAMPLE: Sixty individuals participated in the study. Left and right contralateral ARTs were obtained in two conditions. In the alternated condition, the probe tone presentation was alternated with the presentation of the reflex activating clicks. In the simultaneous condition, the probe tone and the clicks were presented simultaneously. Binaural summation was calculated by subtracting the ARTs obtained in the simultaneous condition from the ARTs obtained in the alternated condition.
RESULTS: MANOVA on ARTs revealed no significant gender or ear effects. The ARTs were significantly lower/better in the simultaneous condition compared to the alternated condition.
CONCLUSIONS: Binaural summation was 4 dB or higher in 88% of the ears and 6 dB or higher in 76% of ears. Stimulation of six out of the total 120 (0.5%) ears resulted in worse thresholds in the simultaneous condition compared with the alternating condition, suggesting binaural interference.

Entities:  

Keywords:  Acoustic reflex; binaural interference; binaural summation

Mesh:

Year:  2018        PMID: 29433374     DOI: 10.1080/14992027.2018.1435914

Source DB:  PubMed          Journal:  Int J Audiol        ISSN: 1499-2027            Impact factor:   2.117


  1 in total

1.  Speech Perception in Bilateral Hearing Aid Users With Different Grades of Asymmetric Hearing Loss.

Authors:  Ulrich Hoppe; Anne Hast; Thomas Hocke
Journal:  Front Neurosci       Date:  2022-01-26       Impact factor: 4.677

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.